Literature DB >> 7468877

A financial analysis of Hodgkin lymphoma staging.

M P Corder, P A Lachenbruch, S G Lindle, J H Sisson, P S Johson, J T Kosier.   

Abstract

A clinical algorithm was developed for staging of Hodgkin disease. This represented the treatment logic employed in a specified time period and was used to categorize charges incurred in the staging of 50 consecutive patients who underwent this process at a university hospital. Charges were categorized as: necessary (in concordance with the algorithm), justifiable (a result of care for a separate medical disorder or for consideration of distance), and perceived excess (neither necessary nor justifiable). Thirty per cent of the total charges were identified as perceived excess. Hospitalization accounted for 68 per cent and laboratory charges 22 per cent of the perceived excess charges. Fifty-eight per cent of the patients had a percentage of perceived excess bed charges exceeding 30 per cent of the total. Perceived excess medical hospitalization correlated positively with time from diagnosis to treatment decision. It is recommended that attempts to reduce the expense of Hodgkin lymphoma staging be directed at decreasing hospitalization.

Entities:  

Mesh:

Year:  1981        PMID: 7468877      PMCID: PMC1619668          DOI: 10.2105/ajph.71.4.376

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  7 in total

1.  Medical technology -- a different view of the contentious debate over costs.

Authors:  T W Moloney; D E Rogers
Journal:  N Engl J Med       Date:  1979-12-27       Impact factor: 91.245

2.  TRUTH IN ADVERTISING DRUG PRODUCTS.

Authors:  A J Cramp
Journal:  Am J Public Health (N Y)       Date:  1920-10

3.  Clinical algorithms for cancer chemotherapy--systems for community-based consultant-extenders and oncology centers.

Authors:  E Mesel; D D Wirtschafter; J T Carpenter; J R Durant; C Henke; E A Gray
Journal:  Methods Inf Med       Date:  1976-07       Impact factor: 2.176

4.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

5.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

6.  A consultant-extender system for breast cancer adjuvant chemotherapy.

Authors:  D Wirtschafter; J T Carpenter; E Mesel
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

7.  Physician's assistants and clinical algorithms in health care delivery. A case study.

Authors:  G Charles; D H Stimson; M D Maurier; J C Good
Journal:  Ann Intern Med       Date:  1974-12       Impact factor: 25.391

  7 in total
  1 in total

1.  To hell with economics?

Authors:  B Littenberg; D Neuhauser
Journal:  Am J Public Health       Date:  1981-04       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.